Renovaro Biosciences (RENB) Q4 2022 Earnings

9MarExpected
Q3 2021
Q4 2021
Q1 2022
Q4 2022
-1.7
-1.13
-0.57
0

Details

Expected EPS
0
Actual EPS
-1.7
Surprise EPS
-1.7
Surprise Percent
+∞%

Description

Renovaro Biosciences (RENB) has reported earnings of -1.7 per share for Q4 2022.

0 Comments

Share your thoughts